Bahk Jae-Hyon, Sung Joohon, Jang In-Jin
Department of Anesthesiology and Clinical Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Korea.
Anesth Analg. 2002 Dec;95(6):1586-9, table of contents. doi: 10.1097/00000539-200212000-00021.
The laryngeal mask airway (LMA) has been used successfully as both a ventilatory device and a conduit for tracheal intubation. In this double-blinded, randomized study, we examined whether pretreatment with lidocaine spray, ketamine anesthesia, and LMA insertion could be used as airway management that could maintain spontaneous breathing in children. After IV premedication with midazolam 0.05 mg/kg and glycopyrrolate 0.005 mg/kg, 90 patients were randomly allocated to 1 of 2 main groups for the administration of either propofol or ketamine: 40 patients received 2.5, 3.0, 3.5, or 4.0 mg/kg of propofol IV (n = 10 each), whereas 50 patients received 2.0, 2.5, 3.0, 3.5, or 4.0 mg/kg of ketamine IV (n = 10 each). Only in the ketamine group was lidocaine spray applied to the oropharynx 1 min before anesthesia induction. After injection of the designated drug, self-respiration, airway obstruction, and jaw relaxation were checked. Self-respiration, laryngospasm coughing, gagging, swallowing, biting or tongue movements, secretions, and head or limb movements after LMA insertion were graded. All variables were graded as satisfactory, acceptable, or unsatisfactory. The overall result was considered satisfactory if all criteria were satisfactory; acceptable if all were better than acceptable, but at least one acceptable criterion was included; and unsatisfactory if at least one criterion was unsatisfactory. Overall satisfactory or acceptable results in every patient were achieved only in the ketamine 3.0 or 3.5 mg/kg subgroups. No propofol dose was completely satisfactory; most cases involved apnea or airway obstruction. Ketamine and lidocaine spray were appropriate for LMA insertion, which may be a safe method for management of difficult airway in children.
Ketamine and lidocaine spray appear to be appropriate for laryngeal mask airway (LMA) insertion in children. Thus, apnea and airway obstruction, the two most serious and frequent complications of propofol, can be avoided during LMA insertion.
喉罩气道(LMA)已成功用作通气设备和气管插管的导管。在这项双盲随机研究中,我们检查了利多卡因喷雾预处理、氯胺酮麻醉和LMA插入是否可用作能维持儿童自主呼吸的气道管理方法。在静脉注射咪达唑仑0.05mg/kg和格隆溴铵0.005mg/kg进行术前用药后,90例患者被随机分为2个主要组之一,分别给予丙泊酚或氯胺酮:40例患者静脉注射2.5、3.0、3.5或4.0mg/kg丙泊酚(每组n = 10),而50例患者静脉注射2.0、2.5、3.0、3.5或4.0mg/kg氯胺酮(每组n = 10)。仅在氯胺酮组中,在麻醉诱导前1分钟将利多卡因喷雾应用于口咽。注射指定药物后,检查自主呼吸、气道阻塞和下颌松弛情况。对LMA插入后的自主呼吸、喉痉挛咳嗽、 gag反射、吞咽、咬或舌运动、分泌物以及头部或肢体运动进行分级。所有变量分为满意、可接受或不满意。如果所有标准都满意,则总体结果视为满意;如果所有标准都优于可接受,但至少有一个可接受标准,则视为可接受;如果至少有一个标准不满意,则视为不满意。仅在氯胺酮3.0或3.5mg/kg亚组中,每位患者均获得了总体满意或可接受的结果。没有丙泊酚剂量完全令人满意;大多数病例涉及呼吸暂停或气道阻塞。氯胺酮和利多卡因喷雾适用于LMA插入,这可能是管理儿童困难气道的一种安全方法。
氯胺酮和利多卡因喷雾似乎适用于儿童喉罩气道(LMA)插入。因此,在LMA插入期间可避免丙泊酚最严重和最常见的两种并发症,即呼吸暂停和气道阻塞。